Trivascular

Merged

Embrace the evidence

Santa Rosa, United States · Founded 1999 · $267.8M raised

Employees
201–500
Founded
1999
Business Model
B2B
Total Funding
$267.8M
Last Round
$40.0M Series ENov 2013
Rounds
7

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

TriVascular, now part of Endologix, develops endovascular aneurysm repair (EVAR) solutions for abdominal aortic aneurysms. They pioneered technologies for optimal patient outcomes in vascular disease, including the DETOUR System. Focused on disruptive innovation, clinical evidence, and physician training with VR.

Summary

Trivascular is a Biotech company based in Santa Rosa, United States, founded in 1999. It has raised $267.8M in total across 7 rounds, most recently a $40.0M Series E round in Nov 2013. Investors include New Enterprise Associates, MPM Capital and Kaiser Permanente Ventures.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ESeries ENov 2013
$40.0M

Sign up to see all 7 events

Funding: Venture Round through Series E. Amounts, valuations, and investors where available.

Investors

Similar Companies

ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Trivascular on Indexed.vc
<a href="https://indexed.vc/companies/trivascular"><img src="https://indexed.vc/api/badge/company/trivascular" alt="Trivascular on Indexed.vc" width="260" height="76" /></a>